| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972672 | The Journal of Heart and Lung Transplantation | 2008 | 7 Pages |
Abstract
These data suggest that aggressive treatment of the underlying plasma cell clone after HT may improve long-term outcomes in patients with cardiac amyloid. HT followed by SCT is feasible and offers the possibility of remission for carefully selected patients with cardiac amyloidosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martha Q. MD, Angela MD, Suzanne R. MD, Shaji MD, Robert A. MD, S. Vincent MD, Brooks S. MD, Richard J. MD, Robert P. MD, Sudhir S. MD, Alfredo L. MD, Joseph A. MD, Thoralf M. MD, Richard C. MD, Christopher G.A. MD, Dennis A. MD, Mark R. MD, Morie A. MD,